Skip to Content

Huamin Wang, M.D., Ph.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, (Term Tenure) Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Associate Professor, The University of Texas Graduate School of Biomedical Sciences, Houston, TX

Education & Training

Degree-Granting Education

1999 The University of Texas Graduate School of Biomedical Sciences, Houston, TX, PhD, Biochemistry & Molecular Biology
1987 Tongji Medical University, Wuhan, China, MD, Medicine, Certified by Educational Commission for Foreign Medical Graduates in May 1998

Board Certifications

7/2003 Diplomat of the American Board of Pathology in Combined Anatomical Pathology and Clinical Pathology

Selected Publications

Peer-Reviewed Original Research Articles

1. Su CH, Zhao R, Zhang F, Qu C, Chen B, Feng YH, Phan L, Chen J, Wang H, Wang H, Yeung SC, Lee MH. 14-3-3sigma exerts tumor suppressor activity mediated by regulation of COP1 stability. Cancer Res 71(3):884-94, 2011. PMCID: PMC3358120.
2. Yang Q, Wang H, Cho HY, Jung SJ, Kim KR, Ro JY, Shen SS. Carcinoma of müllerian origin presenting as colorectal cancer: a clinicopathologic study of 13 Cases. Ann Diagn Pathol 15(1):12-8, 2011. PMID: 20970364.
3. Varadhachary GR, Spector Y, Abbruzzese JL, Rosenwald S, Wang H, Aharonov R, Carlson HR, Cohen D, Karanth S, Macinskas J, Lenzi R, Chajut A, Edmonston TB, Raber MN. Prospective Gene Signature Study Using microRNA to Identify the Tissue of Origin in Patients with Carcinoma of Unknown Primary (CUP). Clin Cancer Res 17(12):4063-70, 2011. PMID: 21531815.
4. Zhao R, Yeung SC, Chen J, Iwakuma T, Su CH, Chen B, Qu C, Zhang F, Chen YT, Lin YL, Lee DF, Jin F, Zhu R, Shaikenov T, Sarbassov D, Sahin A, Wang H, Wang H, Lai CC, Tsai FJ, Lozano G, Lee MH. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. J Clin Invest 121(3):851-65, 2011. PMCID: PMC3049400.
5. Yang G, Chang B, Yang F, Guo X, Cai KQ, Xiao XS, Wang H, Sen S, Hung MC, Mills GB, Chang S, Multani AS, Mercado-Uribe I, Liu J. Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res 16(12):3171-81, 2010. PMCID: PMC2930838.
6. Peng B, Ling J, Lee AJ, Wang Z, Chang Z, Jin W, Kang Y, Zhang R, Shim D, Wang H, Fleming JB, Zheng H, Sun SC, Chiao PJ. Defective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter. Proc Natl Acad Sci U S A 107(34):15193-8, 2010. PMCID: PMC2930541.
7. *Liang JJ, Zhu S, Bruggeman R, Zaino RJ, Evans DB, Fleming JB, Gomez HF, Zander DS, Wang H. High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 19(10):2598-604, 2010. PMID: 20732965.
8. *Peng L, Liang J, Wang H, Song X, Rashid A, Gomez HF, Corley LJ, Abbruzzese JL, Fleming JB, Evans DB, Wang H. High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res 16(14):3734-42, 2010. PMID: 20628027.
9. Overman MJ, Pozadzides J, Kopetz S, Wen S, Abbruzzese JL, Wolff RA, Wang H. Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. Br J Cancer 102(1):144-50, 2010. PMCID: PMC2813754.
10. Lee SO, Abdelrahim M, Yoon K, Chintharlapalli S, Papineni S, Kim K, Wang H, Safe S. Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth. Cancer Res 70(17):6824-36, 2010. PMCID: PMC2988472.
11. *Fang X, Gupta N, Shen SS, Tamboli P, Charnsangavej C, Rashid A, Wang H. Intraluminal polypoid metastasis of renal cell carcinoma in gallbladder mimicking gallbladder polyp. Arch Pathol Lab Med 134(7):1003-9, 2010. PMID: 20586628.
12. Wei D, Wang L, Kanai M, Jia Z, Le X, Li Q, Wang H, Xie K. KLF4a up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. Gastroenterology 139(6):2135-45, 2010. PMCID: PMC3245983.
13. *Abadeer RA, Fleming JB, Deavers MT, Rashid A, Evans DB, Wang H. Metastatic adult granulosa cell tumor mimicking a benign pancreatic cyst. Ann Diagn Pathol 14(6):457-60, 2010. PMID: 21074697.
14. *Song X, Wang H, Logsdon CD, Rashid A, Fleming JB, Abbruzzese JL, Gomez HF, Evans DB, Wang H. Overexpression of receptor tyrosine kinase axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. Cancer 117(4):734-43, 2010. PMID: 20922806.
15. Overman MJ, Maru DM, Charnsangavej C, Loyer EM, Wang H, Pathak P, Eng C, Hoff PM, Vauthey JN, Wolff RA, Kopetz S. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol 28(15):2549-55, 2010. PMID: 20406923.
16. Katz MH, Varadhachary GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DB. Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation. Ann Surg Oncol 17(7):1794-801, 2010. PMCID: PMC2889288.
17. Rubbia-Brandt L, Lauwers GY, Wang H, Majno PE, Tanabe K, Zhu AX, Brezault C, Soubrane O, Abdalla EK, Vauthey JN, Mentha G, Terris B. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 56(4):430-9, 2010. PMID: 20459550.
18. Higgins RJ, Dickinson PJ, LeCouteur RA, Bollen AW, Wang H, Wang H, Corely LJ, Moore LM, Zang W, Fuller GN. Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping. J Neurooncol 98(1):49-55, 2010. PMID: 19967449.
19. Maru DM, Kopetz S, Boonsirikamchai P, Agarwal A, Chun YS, Wang H, Abdalla EK, Kaur H, Charnsangavej C, Vauthey JN, Loyer EM. Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases. Am J Surg Pathol 34(9):1287-94, 2010. PMID: 20697255.
20. Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L, Abbruzzese JL, Gallick GE, Logsdon CD, McConkey DJ, Choi W. Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer. Cancer Res 69(14):5820-8, 7/2009. e-Pub 7/2009. PMID: 19584296.
21. Yu W, Liu J, Xiong X, Ai Y, Wang H. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. Pathology - Research and Practice 205(10):709-15, 2009.
22. Kim MP, Fleming JB, Wang H, Abbruzzese JL, and Gallick GE. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nature Protocols 4(11):1670-80, 2009.
23. Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Kondo S, Wang H, Wang H, Yeung SC, Lee MH. Hypoxia-mediated upregulation of Pim-1 contributes to solid tumor formation. Am J Pathol 175(1):400-11, 2009.
24. Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 16(4):836-47, 2009.
25. *Wang H, Song X, Logsdon C, Zhou G, Evans DB, Abbruzzese JL, Hamilton SR, Tan T-H, Wang H. Proteasome mediated degradation and the functions of hematopoietic progenitor kinase-1 in pancreatic cancer. Cancer Research 69(3):1063-70, 2009. PMID: 19141650.
26. Ji B, Tsou L, Wang H, Gaiser S, Chang DZ, Daniluk J, Bi Y, Grote T, Longnecker DS and Logsdon CD. Ras activity levels control the development of pancreatic diseases. Gastroenterology 137(3):1072-82, 2009. PMID: 19501586.
27. Dong X, Jiao L, Li Y, Evans DB, Wang H, Hess KR, Abbruzzese JL, Li D. Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer. Journal of Clinical Oncology 27(10):1592-9, 2009.
28. *Li J, Wang H, Fuller GN, May S, Wang H. Activation of c-Jun N-terminal kinase correlates with the histologic grade and EGFR expression in diffuse gliomas. J Neurooncol 88(1):11-7, 2008. PMID: 18246408.
29. Ramachandran V, Arumugam T, Wang H, and Logsdon CD. Anterior gradient 2 (AGR2) is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Research 68(19):7811-8, 2008. PMID: 18829536.
30. Miller DV, Wang H, Wang H, Fealey ME, Tazelaar HD. Beta-catenin mutations do not contribute to cardiac fibroma pathogenesis. Pediatr Dev Pathol 11(4):291-4, 2008. PMID: 18078366.
31. *Sanchez AA, Wu T-T, Prieto VG, Rashid A, and Wang H. Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases. Arch Path Lab Med 132(10):1623-29, 2008. PMID: 18834221.
32. Hwang RF, Wang H, Lara A, Gomez H, Chang T, Sieffert N, Moon Y, Ram S, Zimmerman S, Lee JH, Pisters PW, Tamm EP, Fleming JB, Abbruzzese JL, Evans DB. Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol 15(5):1356-66, 2008. PMID: 18256882.
33. Blazer DG 3rd, Ramirez PT, Wang H, Fleming JB. Distal pancreatectomy for isolated metastasis of endometrial carcinoma to the pancreas. J Pancreas 9(1):56-60, 2008. PMID: 18182745.
34. *Liang JJ, Wang H, Rashid A, Tan T-H, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB and Wang H. Expression of MAP4K4 is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 14(21):7043-9, 2008. PMID: 18981001.
35. Baker AF, Koh MY, Williams RR, James B, Wang H, Tate WR, Gallegos A, Von Hoff DD, Han H, Powis G. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer. Pancreas 36(2):178-86, 2008. PMID: 18376310.
36. Wang H, Arun BK, Wang H, Fuller GN, Zhang W, Middleton LP, and Sahin A. IGFBP2 and IGFBP5 overexpression is associated to metastasis in T1 breast carcinomas. The Breast Journal 14(3):261-7, 2008. PMID: 18373644.
37. Wei Y, Xia W, Zhang Z, Liu J, Wang H, Adsay NV, Albarracin C, Yu D, Abbruzzese JL, Mills GB, Bast RC Jr, Hortobagyi GN and Hung M-C. Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian and pancreatic cancers. Mol Carcinog 47(9):701-6, 2008. PMID: 18176935.
38. Dallas NA, Gray MJ, Xia L, Fan F, van Buren G 2nd, Gaur P, Samuel S, Lim SJ, Arumugam T, Ramachandran V, Wang H, Ellis LM. Neuropilin-2-Mediated tumor growth and angiogenesis in pancreatic adenocarcinoma. Clinical Cancer Research 14(24):8052-60, 2008.
39. Tong Z, Kunnumakkara A, Wang H, Matsuo Y, Diagaradjane P, Harikumar K, Ramachandran V, Sung B, Chakraborty A, Bresalier R, Logsdon C, Aggarwal B, Krishnan S, Guha S. Neutrophil Gelatinase-Associated Lipocalin: A Novel Suppressor of Invasion and Angiogenesis in Pancreatic Cancer. Cancer Research 68(15):6100-8, 2008.
40. Abraham SC, Wang H, Wang KK, Wu T-T. Paget's Cells in the Esophagus: Assessment of Their Histopathologic Features and Near-Universal Association with Underlying Esophageal Adenocarcinoma. Am J of Surg Pathol 32(7):1068-74, 2008.
41. Blazer DG 3rd, Kishi Y, Maru DM, Kopetz S, Overman M, Folgelman D, Eng C, Chang DZ, Wang H, Zorzi D, Ribero D, Ellis LM, Clover K, Wolff RA, Curley SA, Abdalla EK and Vauthey J-N. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. Journal of Clinical Oncology 26(33):5344-51, 2008.
42. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. Journal of Clinical Oncology 26(21):3487-95, 2008.
43. Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, and Wolff RA. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. Journal of Clinical Oncology 26(21):3496-502, 2008.
44. Lim SJ, Feig BW, Wang H, Hunt KK, Rodriguez-Bigas MA, Skibber JS, Ellis V, Cleary K, and Chang GJ. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer (60th Annual Best Clinical Paper Award, the Society of Surgical Oncology, 2007). Ann Surg Oncol 15(1):46-51, 2008.
45. Verma A, Guha S, Wang H, Fok JY, Koul D, Abbruzzese J, and Mehta K. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells. Clin Cancer Res 14(7):1997-2005, 2008.
46. Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, Chang DZ, Curley SA, Aballa EK, Ellis LM, Vauthey JN. Bevacizumab Increases the Pathological Response and Reduces the Hepatic Injury in Patients Treated with Oxaliplatin-based Chemotherapy for Colorectal Liver Metastases. Cancer 110(12):2761-7, 2007.
47. Wu T-T, Chirieac LR, Abraham SC, Krasinskas A, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SG. Excellent interobserver agreement on grading the extent of residual carcinoma following preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: A reliable predictor for patient outcome. Am J of Surg Pathol 31(1):58-64, 2007. PMID: 17197919.
48. Wang KL, Wu TT, Choi IS, Wang H, Reseetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer 109(4):658-67, 2007. PMID: 17211865.
49. Baruch AC, Wang H, Staerkel GA, Evans DB, Hwang RF, Krishnamurthy S. Immunocytochemical study of the expression of mesothelin in fine-needle aspiration biopsy specimens of pancreatic adenocarcinoma. Diagn Cytopathol 35(3):143-7, 2007. PMID: 17304533.
50. Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwang R, Vauthey J-N, Abdalla EK, Lee JE, Pisters PWT, and Evans DB. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246(1):52-60, 2007. PMID: 17592291.
51. Wang H and Silva E. Metastatic well-differentiated mucinous adenocarcinoma consistent with pseudomyxoma peritonei. CAP Check Samples 35(8):89-99, 2007. PMID: 7750935.
52. Tseng JF, Pisters PW, Lee JE, Wang H, Gomez HF, Sun CC, Evans DB. The learning curve in pancreatic surgery. Surgery 141(5):694-701, 2007. PMID: 17511115.
53. Yuan P, Wang L, Wei D, Zhang J, Jia Z, Li Q, Le X, Wang H, Yao J. and Xie K. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin A correlates directly with a potent antiangiogenic effects on human pancreatic cancer. Cancer 110(12):2682-90, 2007. PMID: 17973266.
54. Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT. Expression of Annexin A1 in Esophageal and Esophagogastric Junction Adenocarcinomas: Association with Poor Outcome. Clin Cancer Res 12(15):4598-604, 2006. PMID: 16899607.
55. Verma A, Wang H, Manavathi B, Fok JY, Mann AP, Kumar R, Mehta K. Increased Expression of Tissue Transglutaminase in Pancreatic Ductal Adenocarcinoma and Its Implications in Drug Resistance and Metastasis. Cancer Res 66(21):10525-33, 2006. PMID: 17079475.
56. Wang H, Rosen DG, Wang H, Fuller GN, Zhang W, Liu J. Insulin-like growth factor binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types. Mod Pathol 19(9):1149-56, 2006. PMID: 16729015.
57. Wang H, Wang H, Zhang W, Fuller GN. Overexpression of IGFBP5, but not IGFBP3 correlates with the histologic grade of human diffuse glioma: A tissue microarray and immunohistochemical study. Technol Cancer Res Treat 5(3):195-9, 2006. PMID: 16700616.
58. Mann AP, Verma A, Sethi G, Manavathi B, Wang H, Fok JY, Kumar R, Aggarwal BB, Mehta K. Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor kB in cancer cells: Delineation of a novel pathway. Cancer Res 66(17):8788-95, 2006.
59. Mullen JT, Wang H, Yao JC, Lee JH, Perrier ND, Pisters PWT, Lee JE, and Evans DB. Carcinoid tumors of the duodenum. Surgery 138(6):871-8, 2005.
60. Lee E-J, Mircean C, Shmulevich I, Wang H, Liu J, Niemisto A, Kavanagh JJ, Lee J-H, and Zhang W. Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol Cancer 4(7), 2005.
61. Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli M. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Clin Cancer Res 11(1):267-72, 2005. PMID: 15671555.
62. Wang H, Wang H, Zhang W, Huang H, Liao W, and Fuller G N. Analysis of the activation status of Akt, NFkB and Stat3 in human diffuse gliomas. Laboratory Investigation 84(8):941-51, 2004.
63. Hao X, Sun B, Hu L, Lahdesmaki H, Dunmire V, Feng Y, Zhang SW, Wang H, Wu C, Wang H, Fuller GN, Symmans WF, Shmulevich I, Zhang W. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer 100(6):1110-22, 2004. PMID: 15022276.
64. Wang H, Actor JK, Indrigo J, Olsen M, Dasgupta A. Asian and Siberian ginseng as a potential modulator of immune function: an in vitro cytokine study using mouse macrophages. (Paul E. Strandjord Young Investigator Award, 6/2006). Clin Chim Acta 327:123-8, 2003. PMID: 12482627.
65. Wang H, Wang H, Shen W, Huang H, Hu L, Ramdas L, Zhou Y, Liao WSL, Fuller GN, Zhang W. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion enhancing genes. Cancer Research 63:4315-4321, 2003. PMID: 12907597.
66. Fuller CE, Wang H, Zhang W, Fuller GN, Perry A. High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH). J Neuropathol Exp Neurol 61(12):1078-84, 12/2002. PMID: 12484570.
67. Casella R, Nudell D, Cozzolino D, Wang H, Lipshultz LI. Primary testicular amyloidosis mimicking tumor in a cryptorchid testis. Urology 59(3):445, 2002. PMID: 11880098.
68. Wang H, Napoli KL, Strobel HW. Cytochrome P450 3A9 catalyzes the metabolism of progesterone and other steroid hormones. Mol Cell Biochem 213(1-2):127-35, 10/2000. PMID: 11129951.
69. Rowlands JC, Wang H, Hakkak R, Ronis MJ, Strobel HW, Badger TM. Chronic intragastric infusion of ethanol-containing diets induces CYP3A9 while decreasing CYP3A2 in male rats. J Pharmacol Exp Ther 295:747-52, 2000. PMID: 11046114.
70. Kelly PA, Wang H, Napoli KL, Kahan BD, Strobel HW. Metabolism of cyclosporine by cytochromes P450 3A9 and 3A4. Eur J Drug Metab Pharmacokinet 24(4):321-8, 1999. PMID: 10892895.
71. Wang H, Strobel HW. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. Arch Biochem Biophys 344(2):365-72, 1997. PMID: 9264551.
72. Wang H, Kawashima H, Strobel HW. cDNA cloning of a novel CYP3A from rat brain. Biochem Biophys Res Commun 221(1):157-62, 4/1996. PMID: 8660328.
73. Tao Y, Wang H, Fu Y, Yin C, and Xu F. Epidemiological studies on the effect of drinking natural mineral water on human health in Wen Tang. Journal of Environment and Health 9(3):101-3, 1992.
74. Wang S, Zhang X, Li H, Song S, Luo J, Yang Y, and Wang H. Health effect and economic loss resulting from the environment pollution caused by small electroplating plants. Journal of Hygiene Research 21:38-42, 1992.
75. Chen X, Lin P, Lu Y, Cang G, Wu C, Guo R, Zhao Y, Wu X, and Wang H. Health effect and economic loss resulting from the environment pollution caused by small township smelteries of lead. Journal of Hygiene Research 21:28-33, 1992.
76. Chen X, Lu Y, Lin P, Cang G, Wu C, Gan Y, Sun R, Wu X, and Wang H. Health effect and economic loss resulting from the environment pollution caused by township printing and dyeing mills. Journal of Hygiene Research 21:24-27, 1992.
77. Xu F, Wang H, and Cao Z. Research on economic analysis and strategy to the effect of the environment pollution of township industries on human health. Journal of Hygiene Research 21:1-23, 1992.
78. Zhao D, Yang Z, Wang H, and Cao Z. Studies on the environment pollution caused by township asphalt felt plants: its health effect, economic analysis and preventive strategies. Journal of Hygiene Research 21:65-68, 1992.
79. Fu Y, Wu X, Cao Z, Wang H, and Yin C. The effect of air pollution caused by the sulfur-smelting with local methods on the health of school children. China Public Health 8(11):487-8, 1992.
80. Tao Y, Wang H, Liu J, Tan Y, and Li W. Utilization of geothermal water and its effect on human health. Journal of Hygiene Research 21(1):21-3, 1992.
81. Qin Y, Guo R, Yin X, Song X, Wu Z, Shen S, Wang H, and Li S. Studies on the subchronic toxicity of dimethyl fumarate. Journal of Hygiene Research 20(2):23-25, 1991.
82. Yin C and Wang H. A method for the determination of SIgA in saliva. Journal of Hygiene Research 19(6):22-24, 1990.
83. Li S, Liu J, Tan Y, Fu J, Yin C, Wang H, Wang X, Shen S, Li J, Song X, and Xu F. Investigation on the status of air pollution around poultry farms. China Public Health 6(1):7-8, 1990.
84. Li S, Liu J, Tan Y, Fu J, Yin C, Wang H, and Xu F. Studies on health protection zone around large-scale poultry farms. China Public Health 6(9):397-397, 1990.
85. Wang H, Yin C, Fu Y, and Xu F. Sulphur-smelting with local methods of rural industries impacts on the level of SIgA in school children saliva. Chinese Journal of Public Health 8(6):378-379, 1990.
86. Li G, Xu Z, Tan Y, Wang H. Smoking and lung cancer in seven cities of Liaoning Province. Journal of Environment and Health 6(5):1-4, 1989.

Invited Articles

1. Akkiprik M, Feng Y, Wang H, Chen K, Hu L, Sahin A, Krishnamurthy S, Ozer A, Hao X, Zhang W. Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer. Breast Cancer Res 10(4):212, 2008. PMCID: PMC2575530.

Letters to the Editor

1. Overman MJ, Wolff RA, Wang H. Reply to comment: Cetuximab in small bowel adenocarinoma (SBA): a new friend? British Journal of Cancer 103(8):1306, 10/2010. PMCID: PMCPMC2967067.

Grant & Contract Support

Title: Hematopoietic Progenitor Kinase 1: A Novel Negative Regulator of Ras Signaling in Pancreatic Cancer
Funding Source: G. S. Hogan Gastrointestinal Cancer Research Fund, The University of Texas M.D. Anderson Cancer Center
Role: Principal Investigator
Duration: 9/1/2011 - 8/31/2014
Title: A Novel Preoperative Platform in Pancreatic Cancer for Mechanistic Studies
Funding Source: Lustgarten Foundation for Pancreatic Cancer
Role: Co-Investigator
Principal Investigator: Gauri Varadhachary
Duration: 5/1/2011 - 4/30/2014
Title: Proteasome-medicated Degradation of Hematopoietic Progenitor Kinase 1 in Pancreatic Cancer
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 4/1/2011 - 3/31/2014
Title: Conditional ablation of stellate cells to determine their role in pancreatitis and pancreatic cancer
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: Rosa Hwang
Duration: 12/1/2010 - 11/30/2012
Title: Stellate cell-specific targeting in pancreatic cancer
Funding Source: American Association for Cancer Research (AACR) - PanCAN, Innovative Grant
Role: Co-Investigator
Principal Investigator: Rosa Hwang
Duration: 7/1/2010 - 6/30/2012
Title: Role of Dietary Zinc Transporter ZIP4 in Pancreatic Cancer
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: Min Li
Duration: 4/2010 - 1/2015
Title: Wnt signaling in pancreatic cancer associated-stroma
Funding Source: The Lustgarten Foundation
Role: Co-Investigator
Principal Investigator: Rosa Hwang
Duration: 1/1/2010 - 12/31/2010
Title: Stromal Periostin in Pancreatitis and Pancreas Cancer
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Rosa Hwang
Duration: 12/1/2009 - 11/30/2014
Title: Roles of MicroRNAs and Ultraconserved Genes in Pancreatic Cancers
Funding Source: American Association for Cancer Research (AACR)
Role: Co-Investigator
Principal Investigator: Calin, G
Duration: 7/1/2009 - 6/30/2011
Title: Functions of ubiquitin E3 ligase, Fbw8, in proteasome-mediated degradation of hematopoietic progenitor kinase 1 in pancreatic cancer
Funding Source: Institutional Research Grant (Basic Laboratory Research), The University of Texas M. D. Anderson Cancer Center
Role: Principal Investigator
Duration: 7/1/2009 - 6/30/2011
Title: KLF4 Genetic and epigenetic changes in human pancreatic cancer
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Xie, Keping
Duration: 9/2008 - 7/2013
Title: Survivin and interferon as a cancer vaccine for pancreatic cancer
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Chang, David Z.
Duration: 9/2008 - 8/2010
Title: Lockton Grant Matching Program for Pancreatic Cancer Research, M. D. Anderson Cancer Center
Funding Source: The University of Texas M.D. Anderson Cancer Center
Role: Principal Investigator
Duration: 7/1/2008 - 12/31/2008
Title: Functional study of hematopoietic progenitor kinase-1 (HPK1) in pancreatic cancer
Funding Source: American Association for Cancer Research-PanCAN Career Development Award
Role: Principal Investigator
Duration: 7/1/2007 - 6/30/2010
Title: Clinicopathologic characteristics and molecular alterations of pancreatic ductal adenocarcinoma in patients of 45 years of age and younger
Funding Source: Fellow's Intramural Research Grant/The University of Texas M.D. Anderson Cancer Center
Role: Mentor for FY06-07 Fellow Research Project Award (Fellow: John Liang, MD, PhD)
Principal Investigator: John J. Liang
Duration: 7/1/2006 - 6/30/2007
Title: Pancreatic Cancer Tissue core. Specialized Program of Research Excellence (SPORE) in Pancreatic Cancer
Funding Source: NIH/NCI
Role: Core Leader
Principal Investigator: James L. Abbruzzese
Duration: 9/30/2003 - 8/31/2008
Title: Prognostic significance of insulin-like growth factor binding proteins in breast and ovarian cancers
Funding Source: Fellow's Intramural Research Grant/The University of Texas M. D. Anderson Cancer Center
Role: Principal Investigator
Duration: 7/1/2003 - 6/30/2004

Last updated: 5/6/2014